News - Page 3

After a robust three-day rally, the stock market experienced a cautious pause as the week ended. The Dow Jones Industrial Average dipped by 0.2%, while the S&P 500 and Nasdaq Composite hovered near flat. The S&P 500 increased by 3.8%, the Nasdaq

Abercrombie & Fitch has achieved a notable financial triumph with its 38% leap in earnings per share (EPS) to $3.29 in 2024, driven by strategic innovation and operational excellence. The retailer has successfully modernized its brand, leading to a 9% increase in

Thermo Fisher Scientific is a reliable and stable company amid economic uncertainty and potential recession. It provides essential analytical instruments, reagents, and services for labs worldwide, focusing on continuous innovation. Over 80% of its revenue comes from recurring sources, offering predictable income

Economic turbulence spurred by tariff wars and recession signals impacts banking and financial sectors. Houlihan Lokey, Inc. thrives despite instability, excelling in Corporate Finance, Financial Restructuring, and Valuation Advisory. Hedge funds and banks face challenges as profitability declines and loan loss reserves

Tesla, Inc. (NASDAQ:TSLA) is a key player in the electric vehicle market, facing both admiration and challenges as it prepares to release its earnings report. Jim Cramer emphasizes Tesla’s need for reinvention, suggesting a leap toward robotics and AI to drive future

Weibo serves as a reminder that not every tech stock becomes a multi-bagger. Key metrics for potential success include a growing Return on Capital Employed (ROCE) and expanding capital base. Weibo’s ROCE fell from a five-year peak of 15% to 8.9%, close

EverCommerce Inc. has recently experienced a notable stock price increase of over 10% on NASDAQGS, drawing increased investor interest. The company’s current stock price is $9.96, significantly below its estimated intrinsic value of $13.94, indicating potential undervaluation. Characterized by high volatility and

The stock market is experiencing a significant transformation, leading to the fall of former leaders and the unexpected rise of previously overlooked players. Jim Cramer emphasizes that market sentiment heavily influences stock trends, challenging conventional wisdom. Tariffs and international trade tensions are

Insider purchases at Evolent Health total US$1.3 million recently, indicating strong internal confidence. Seth Blackley, a co-founder, led significant purchases, including the largest single insider buy of US$498,000. Insiders own 1.6% of the company, reflecting alignment with external shareholders, valued at about

Rocket Pharmaceuticals faces a crucial moment in its stock market journey, balancing innovation against fiscal challenges. The company is at the forefront of gene therapies but remains unprofitable, with expenditures surpassing revenue. As of late 2024, Rocket’s cash reserve of $372 million